Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > Is that the royal "We"

<< Previous

Bullboard Posts

Next >>

Comment by PTBaileyon Feb 08, 2022 12:44pm

45 Views

Post# 34409139

RE:RE:RE:Is that the royal "We"

"insecurities" if you only knew.

You are the type of person with such low emotional intelligence and emotional maturity that it makes you incapable of seeing positivies in others, especially those you don't like.

It makes you feel more superior to name call, insult and put others down, and by putting others down you feel elevated.

On the othe hand even though I have no respect for you I do find some value in what you post and think you know more about trading and the stock market than I do. But I have a business to run and don't have the time to focus on it full time like you probably do.

On the inside you are a very small person.

<< Previous

Bullboard Posts

Next >>

Thesis Gold makes high-grade discovery at Ring Zone